Page
%P
-
Article
Open AccessHER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?
Liposarcomas are among the most common mesenchymal malignancies. However, the therapeutic options are still very limited and so far, targeted therapies had not yet been established. Immunotherapy, which has be...
-
Article
FDG Whole-Body PET/MRI in Oncology: a Systematic Review
The recent advance in hybrid imaging techniques enables offering simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) in various clinical fields. 18F-fluorodeoxyglucose (FDG) PET has b...